We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01936064
Recruitment Status : Unknown
Verified October 2016 by Abiodun Popoola, Lagos State University.
Recruitment status was:  Recruiting
First Posted : September 5, 2013
Last Update Posted : November 1, 2016
Sponsor:
Information provided by (Responsible Party):
Abiodun Popoola, Lagos State University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 2017
Estimated Study Completion Date : January 2018
Publications:
Newly isolated compounds from West African Sorghum bicolor leaf sheaths Jobelyn® show potential in cancer immunosurveillance DOI: http://dx.doi.org/10.14312/2052-4994.2016-6